Share-Based Compensation (Tables)

12 Months Ended

Sep. 30, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Share-Based Compensation Expense

The following table summarizes the components of share-based compensation expense in the Consolidated Statements of Comprehensive Income during the fiscal years ended September 30, 2025, 2024 and 2023 (in thousands):

	For the Fiscal Year Ended September 30,
	2025		2024		2023
Equity classified awards	$	26,868	$	10,735	$	10,759
Liability classified awards	10,137		3,677		—
Employee stock purchase plan	1,583		619		—
Total share-based compensation expense	$	38,588	$	15,031	$	10,759

Schedule of Nonvested Restricted Stock Units Activity

A summary of the changes in the Company’s restricted stock is as follows (in thousands, except share data):

	For the Fiscal Year Ended September 30,
	2025			2024			2023
	Shares		Weighted Average Grant Date Fair Value Per Share	Shares		Weighted Average Grant Date Fair Value Per Share	Shares		Weighted Average Grant Date Fair Value Per Share
Unvested shares, beginning balance	509,171		31.59	824,280		28.41	715,724		29.34
Shares awarded	381,995		78.61	110,113		45.70	210,412		26.21
Shares vested	(391,077)		30.12	(421,873)		29.05	(76,963)		31.01
Shares forfeited	(21,478)		30.60	(3,349)		32.11	(24,893)		28.36
Unvested shares, ending balance	478,611		70.36	509,171		31.59	824,280		28.41
Aggregate grant date fair value of awards	$	30,027		$	5,032		$	5,514
Compensation expense recorded upon vesting of awards	11,538			8,416			8,717
Unrecognized compensation expense at fiscal year-end	24,464			6,331			9,766
Weighted average recognition period remaining, in years	4.1			2.5			2.5

Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award, Options, expected to Vest

The restricted shares granted under the Equity Incentive Plan will vest, as applicable, as follows:

Fiscal Year	Number of Shares
2026	81,389
2027	66,722
2028	149,134
2029	151,366
2030	30,000
Total	478,611